YTHDF3 Antibody - BSA Free

Novus Biologicals | Catalog # NBP2-94636

Novus Biologicals
Loading...

Key Product Details

Species Reactivity

Validated:

Human, Mouse, Rat

Cited:

Human, Mouse

Applications

Validated:

Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot, Immunocytochemistry/ Immunofluorescence, Immunoprecipitation

Cited:

Immunocytochemistry/ Immunofluorescence

Label

Unconjugated

Antibody Source

Polyclonal Rabbit IgG

Format

BSA Free
Loading...

Product Specifications

Immunogen

Recombinant fusion protein containing a sequence corresponding to amino acids 1-275 of human YTHDF3 (NP_689971.4). MSATSVDQRPKGQGNKVSVQNGSIHQKDAVNDDDFEPYLSSQTNQSNSYPPMSDPYMPSYYAPSIGFPYSLGEAAWSTAGDQPMPYLTTYGQMSNGEHHYIPDGVFSQPGALGNTPPFLGQHGFNFFPGNADFSTWGTSGSQGQSTQSSAYSSSYGYPPSSLGRAITDGQAGFGNDTLSKVPGISSIEQGMTGLKIGGDLTAAVTKTVGTALSSSGMTSIATNSVPPVSSAAPKPTSWAAIARKPAKPQPKLKPKGNVGIGGSAVPPPPIKHNMN

Clonality

Polyclonal

Host

Rabbit

Isotype

IgG

Theoretical MW

63 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.

Scientific Data Images for YTHDF3 Antibody - BSA Free

Western Blot: YTHDF3 AntibodyBSA Free [NBP2-94636]

Western Blot: YTHDF3 AntibodyBSA Free [NBP2-94636]

Western Blot: YTHDF3 Antibody [NBP2-94636] - Western blot analysis of extracts of HepG2 cells, using YTHDF3 antibody (NBP2-94636) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 90s.
Immunohistochemistry-Paraffin: YTHDF3 Antibody - BSA Free [NBP2-94636]

Immunohistochemistry-Paraffin: YTHDF3 Antibody - BSA Free [NBP2-94636]

Immunohistochemistry-Paraffin: YTHDF3 Antibody [NBP2-94636] - Immunohistochemistry of paraffin-embedded rat brain using YTHDF3 Rabbit pAb (NBP2-94636) at dilution of 1:500 (40x lens). Perform high pressure antigen retrieval with 10 mM citrate buffer pH 6.0 before commencing with IHC staining protocol.
Western Blot: YTHDF3 AntibodyBSA Free [NBP2-94636]

Western Blot: YTHDF3 AntibodyBSA Free [NBP2-94636]

Western Blot: YTHDF3 Antibody [NBP2-94636] - Western blot analysis of extracts of Mouse liver, using YTHDF3 antibody (NBP2-94636) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 90s.
Immunohistochemistry-Paraffin: YTHDF3 Antibody - BSA Free [NBP2-94636]

Immunohistochemistry-Paraffin: YTHDF3 Antibody - BSA Free [NBP2-94636]

Immunohistochemistry-Paraffin: YTHDF3 Antibody [NBP2-94636] - Immunohistochemistry of paraffin-embedded mouse brain using YTHDF3 Rabbit pAb (NBP2-94636) at dilution of 1:500 (40x lens). Perform high pressure antigen retrieval with 10 mM citrate buffer pH 6.0 before commencing with IHC staining protocol.
Immunoprecipitation: YTHDF3 Antibody - BSA Free [NBP2-94636]

Immunoprecipitation: YTHDF3 Antibody - BSA Free [NBP2-94636]

Immunoprecipitation: YTHDF3 Antibody [NBP2-94636] - Immunoprecipitation analysis of 300ug extracts of HT-1080 cells using 3ug YTHDF3 antibody (NBP2-94636). Western blot was performed from the immunoprecipitate using YTHDF3 antibody (NBP2-94636) at a dilution of 1:1000.
YTHDF3 Antibody - BSA Free

Immunocytochemistry/ Immunofluorescence: YTHDF3 Antibody - BSA Free [YTHDF3] -

Immunocytochemistry/ Immunofluorescence: YTHDF3 Antibody - BSA Free [YTHDF3] - Immunofluorescence analysis of HeLa cells using YTHDF3 Rabbit pAb at dilution of 1:50 (40x lens). Secondary antibody: Cy3 Goat Anti-Rabbit IgG (H+L) at 1:500 dilution. Blue: DAPI for nuclear staining.
YTHDF3 Antibody - BSA Free

Immunocytochemistry/ Immunofluorescence: YTHDF3 Antibody - BSA Free [YTHDF3] -

Immunocytochemistry/ Immunofluorescence: YTHDF3 Antibody - BSA Free [YTHDF3] - Immunofluorescence analysis of NIH/3T3 cells using YTHDF3 Rabbit pAb at dilution of 1:50 (40x lens). Secondary antibody: Cy3 Goat Anti-Rabbit IgG (H+L) at 1:500 dilution. Blue: DAPI for nuclear staining.
YTHDF3 Antibody - BSA Free

Western Blot: YTHDF3 Antibody - BSA Free [NBP2-94636] -

G3BP1 and YTHDF3 are cytoprotective proteins. (A) ARPI stress induced SG formation is reversible. LNCaP cells were unstressed, ARPI stressed or rescued from treatment. The cells were then stained with anti-G3BP1 and anti-YTHDF3 antibodies to reveal the SGs. Quantification of SGs is shown on the right-side panel. Note that ARPI stress- induced SG formation was reversed when treatment was withdrawn. (B) ARPI stress induced reduction in AR protein was restored to steady state level following stress removal. (C–F) KD of G3BP1 or YTHDF3 reduced cell survival in LNCaP cells. LNCaP cells transfected with siControl, siG3BP1 or siYTHDF3 were unstressed or treated with ARPI stress for 8, 24 and 48 h. The cell lysates were subjected to Western blotting for the indicated antibodies. Note that ARPI stress enhanced PARP cleavage in siG3BP1 (C) and siYTHDF3 (D) cells compared to control cells (8 h treatment). The above cells were subjected to IF using antibodies against activated BAX (2D2), an indicator of apoptosis (E). BAX positive cells are indicated by arrowheads. (F) Quantification of BAX activation. Note that acute ARPI stress strongly activated BAX in siG3BP1 and siYTHDF3 cells compared to control cells (8 h treatment). The results are an average of three independent experiments with ***P < 0.001. Scale 10 μm. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34939643), licensed under a CC-BY license. Not internally tested by Novus Biologicals.
YTHDF3 Antibody - BSA Free

Western Blot: YTHDF3 Antibody - BSA Free [NBP2-94636] -

YTHDF3 translationally regulates AR mRNA. (A) Knockdown (KD) of G3BP1 did not affect rate of synthesis of AR protein, while KD of YTHDF3 reduced the rate of synthesis of AR protein as measured by Click chemistry (see Methods for details). (B) KD of YTHDF3 reduced the level of AR mRNA in the PSs. (C) KD of YTHDF3 did not affect the total mRNA level of AR. (D) YTHDF3 binds to AR mRNA in the PSs. (E) m6A-modified AR mRNA is reduced in the PSs after ARPI stress. Results are presented as an average of 3 independent experiments with ***P < 0.001, **P < 0.01, n.s., non-significant. (F) Model illustrating the regulation of AR mRNA during ARPI stress. Under the unstressed condition, AR mRNA is present as two fractions. m6A-modified translatable AR mRNA fraction, regulated by METTL3, is associated with YTHDF3 in the PSs, and m6A-unmodified untranslatable AR mRNA fraction is associated with G3BP1 in the non-PS fraction. When the cells are exposed to ARPI stress, PSs disassemble, and the m6A-modified AR mRNA and associated YTHDF3 is redistributed from the PSs to SGs to form the AR mRNA-YTHDF3 cluster. At the same time, G3BP1 associated m6A-unmodified AR mRNA also redistributes from the non-PS fraction to SGs to form the AR mRNA-G3BP1 cluster. Thus, these two ribonucleoprotein (RNP) clusters, AR mRNA-YTHDF3 and AR mRNA-G3BP1, co-exist in the SG. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34939643), licensed under a CC-BY license. Not internally tested by Novus Biologicals.
YTHDF3 Antibody - BSA Free

Western Blot: YTHDF3 Antibody - BSA Free [NBP2-94636] -

AR mRNA supports SG formation in response to ARPI stress treatment. (A) AR knockdown (KD) using siRNAs delayed the formation of SGs. LNCaP cells were transfected with siControl or siAR siRNAs, -/+ ARPI stress for different time points (30 min, 60 min and 75 min), and stained with anti-YTHDF3 and anti-G3BP1 antibodies to analyse SGs. Note that SG formation is significantly delayed at 30 and 60 min, while this effect is gradually lost at 75 min of treatment. (B) Quantification of SGs. (C) KD of AR did not affect the level of different SG proteins. (D) Treatment with AR degrader, ARD-61, did not affect the level of SGs in response to ARPI stress. (E) Quantification of SGs. ARD-61 treatment reduced the level of AR protein as revealed by Western blot (F) without affecting the level of AR mRNA as revealed by qRT-PCR (G). The results are an average of three independent experiments with **P < 0.01. n.s., non-significant. Scale 10 μm. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34939643), licensed under a CC-BY license. Not internally tested by Novus Biologicals.
YTHDF3 Antibody - BSA Free

Western Blot: YTHDF3 Antibody - BSA Free [NBP2-94636] -

G3BP1 and YTHDF3 are cytoprotective proteins. (A) ARPI stress induced SG formation is reversible. LNCaP cells were unstressed, ARPI stressed or rescued from treatment. The cells were then stained with anti-G3BP1 and anti-YTHDF3 antibodies to reveal the SGs. Quantification of SGs is shown on the right-side panel. Note that ARPI stress- induced SG formation was reversed when treatment was withdrawn. (B) ARPI stress induced reduction in AR protein was restored to steady state level following stress removal. (C–F) KD of G3BP1 or YTHDF3 reduced cell survival in LNCaP cells. LNCaP cells transfected with siControl, siG3BP1 or siYTHDF3 were unstressed or treated with ARPI stress for 8, 24 and 48 h. The cell lysates were subjected to Western blotting for the indicated antibodies. Note that ARPI stress enhanced PARP cleavage in siG3BP1 (C) and siYTHDF3 (D) cells compared to control cells (8 h treatment). The above cells were subjected to IF using antibodies against activated BAX (2D2), an indicator of apoptosis (E). BAX positive cells are indicated by arrowheads. (F) Quantification of BAX activation. Note that acute ARPI stress strongly activated BAX in siG3BP1 and siYTHDF3 cells compared to control cells (8 h treatment). The results are an average of three independent experiments with ***P < 0.001. Scale 10 μm. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34939643), licensed under a CC-BY license. Not internally tested by Novus Biologicals.
YTHDF3 Antibody - BSA Free

Immunocytochemistry/ Immunofluorescence: YTHDF3 Antibody - BSA Free [NBP2-94636] -

AR mRNA supports SG formation in response to ARPI stress treatment. (A) AR knockdown (KD) using siRNAs delayed the formation of SGs. LNCaP cells were transfected with siControl or siAR siRNAs, -/+ ARPI stress for different time points (30 min, 60 min and 75 min), and stained with anti-YTHDF3 and anti-G3BP1 antibodies to analyse SGs. Note that SG formation is significantly delayed at 30 and 60 min, while this effect is gradually lost at 75 min of treatment. (B) Quantification of SGs. (C) KD of AR did not affect the level of different SG proteins. (D) Treatment with AR degrader, ARD-61, did not affect the level of SGs in response to ARPI stress. (E) Quantification of SGs. ARD-61 treatment reduced the level of AR protein as revealed by Western blot (F) without affecting the level of AR mRNA as revealed by qRT-PCR (G). The results are an average of three independent experiments with **P < 0.01. n.s., non-significant. Scale 10 μm. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34939643), licensed under a CC-BY license. Not internally tested by Novus Biologicals.
YTHDF3 Antibody - BSA Free

Immunohistochemistry: YTHDF3 Antibody - BSA Free [NBP2-94636] -

Immunohistochemistry (IHC) analysis of G3BP1 and YTHDF3 in PCA TMAs. PCA tissue microarrays (TMAs) were stained with anti-G3BP1 (A) and anti-YTHDF3 (B) antibodies. A part of the image is enlarged and shown. Quantification of staining is shown on the right-side panels. Statistics of quantification data is presented below respective graphs. Note that G3BP1 expression is increased in ARPI stressed, CRPC and NEPC tissues, while YTHDF3 expression is enhanced in CRPC and NEPC tissues. NHT: neoadjuvant hormonal therapy; CRPC: castration resistant PCA; NEPC: neuroendocrine PCA. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34939643), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Applications for YTHDF3 Antibody - BSA Free

Application
Recommended Usage

Immunocytochemistry/ Immunofluorescence

1:50 - 1:200

Immunohistochemistry

1:100 - 1:500

Immunoprecipitation

1:500 - 1:1000

Western Blot

1:500 - 1:1000

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS (pH 7.3), 50% glycerol

Format

BSA Free

Preservative

0.02% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at -20C. Avoid freeze-thaw cycles.

Background: YTHDF3

Alternate Names

FLJ31657, YTH domain family 3, YTH domain family protein 3, YTH domain family, member 3

Gene Symbol

YTHDF3

Additional YTHDF3 Products

Product Documents for YTHDF3 Antibody - BSA Free

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Product Specific Notices for YTHDF3 Antibody - BSA Free

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Citations for YTHDF3 Antibody - BSA Free

Customer Reviews for YTHDF3 Antibody - BSA Free

There are currently no reviews for this product. Be the first to review YTHDF3 Antibody - BSA Free and earn rewards!

Have you used YTHDF3 Antibody - BSA Free?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs

No product specific FAQs exist for this product.

View all FAQs for Antibodies
Loading...